Elekta Synergy system with Agility 160-leaf MLC now available at Radboud

The first of three newly acquired Elekta (STO:EKTAB) Synergy® treatment systems equipped with Agility™ 160-leaf multi-leaf collimator (MLC) is now up and running clinically at Radboud University Nijmegen Medical Center - making the clinic the first in the Netherlands to use Agility. The first patient, a 48-year-old woman, was treated on September 10 and clinicians have treated 70 additional patients since then, encompassing a wide range of cancers.

"Our first experiences with Agility have gone perfectly - the high leaf speed of Agility has made beam delivery speed much faster, especially with IMRT [Intensity Modulated Radiation Therapy] plans," says René Monshouwer, Ph.D., Clinical Physicist at Radboud. "And, comparing the system with Agility to one without Agility, the leaf transmission is lower."

Dr. Monshouwer adds that the high resolution leaves of Agility and low transmission will help Radboud begin using Agility in stereotactic treatments in the next few months.

"These are more complex treatments involving small structures in close proximity to organs-at-risk, so we expect Agility to benefit those treatments," he says. "Then, once we switch from IMRT to Volumetric Modulated Arc Therapy [VMAT] for those cases, we will see a big advance in the quality and speed of treatment."

Elekta reinvented beam shaping, creating a solution that boasts leaf speeds that are twice as fast as conventional devices. The 160 5 mm leaves can interdigitate to enable treatment of island targets and multiple targets in a single session, and optical leaf positioning technology improves accuracy and increases the reliability and seamlessness of beam shaping. The exceptionally low leaf transmission of less than 0.5 percent enhances treatment delivery while reducing integral dose. The integrated whole results in a sophisticated multi-functional beam-shaping solution.

Two of the three Elekta Synergy systems that Radboud recently acquired will come equipped with Agility as well, a second system for the Nijmegen satellite facility and one for a satellite clinic in Boxmeer, the former becoming clinically operational in November 2012. The Synergy systems with Agility join four other existing Elekta linear accelerators at Radboud University Nijmegen Medical Center. At least one of the systems in Radboud also will be upgraded to Agility.

Source:

Elekta

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). Elekta Synergy system with Agility 160-leaf MLC now available at Radboud. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20121015/Elekta-Synergy-system-with-Agility-160-leaf-MLC-now-available-at-Radboud.aspx.

  • MLA

    Elekta. "Elekta Synergy system with Agility 160-leaf MLC now available at Radboud". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20121015/Elekta-Synergy-system-with-Agility-160-leaf-MLC-now-available-at-Radboud.aspx>.

  • Chicago

    Elekta. "Elekta Synergy system with Agility 160-leaf MLC now available at Radboud". News-Medical. https://www.news-medical.net/news/20121015/Elekta-Synergy-system-with-Agility-160-leaf-MLC-now-available-at-Radboud.aspx. (accessed November 22, 2024).

  • Harvard

    Elekta. 2023. Elekta Synergy system with Agility 160-leaf MLC now available at Radboud. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20121015/Elekta-Synergy-system-with-Agility-160-leaf-MLC-now-available-at-Radboud.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New PULSAR radiation-therapy strategy achieves better tumor control